Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients
Clinical trial NCT02762084 · COMPLETED
Trial details
- NCT number
- NCT02762084
- Sponsor
- PellePharm, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-06
- Primary completion
- 2017-04-24
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.